China Expands Medical Insurance Coverage in New State Council Guidelines
The General Office of the State Council released the “Guidelines on Further Safeguarding and Improving...
Fineline Cube
WuXi Biologics Commences Construction on Microbial Production Base in Chengdu
China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) announced the official...
Sihuan Pharma’s Xuanyuening Granted New Indication Review in China
China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) announced that the National Medical Products Administration...
Johnson & Johnson Launches Tremfya IV in China for Inflammatory Bowel Diseases
US-based Johnson & Johnson (J&J; NYSE: JNJ) announced the commercial launch of Tremfya (guselkumab) intravenous...
Deep Surgery Secures Pre-Series A Funding for Microsurgery Robot Expansion
Guangzhou-based microsurgery robot developer Deep Surgery has secured “tens of millions” of renminbi in a...
ImmuneOnco Appoints Zhuli Wu as Chief Medical Officer to Lead Clinical Strategy
China-based ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) announced the appointment of Zhuli Wu as...
Hengrui Pharmaceuticals Launches Aiweida for HER2-Mutated NSCLC in China
China’s Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced the first commercial shipment of its...
Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System
Suzhou Sinus Medical Technologies Co., Ltd., a China-based medical device innovator, announced that its in-house...
Novartis’ PSMAddition Trial Yields Positive Results for Pluvicto in mHSPC
Swiss pharmaceutical giant Novartis (NYSE: NVS) announced the interim results from its Phase III PSMAddition...
Innovent Biologics’ Xinbiyue Approved for Macau Market
China-based Innovent Biologics Inc. (HKG: 1801) announced that it has received market approval from the...
Innogen Pharma Resubmits Hong Kong IPO Application With Promising Diabetes Drug
China-based Guangzhou Innogen Pharmaceutical Group Co., Ltd. has resubmitted its application for a main board...
Harrow Signs Licensing Deal for Formosa’s Byqlovi in US Market
US-based ophthalmic pharmaceutical company Harrow (NASDAQ: HROW) announced a licensing agreement with Taiwan-based Formosa Pharmaceuticals...
FDA Approves Merck’s Enflonsia for Infant RSV Protection
The US Food and Drug Administration (FDA) granted approval to Merck, Sharp & Dohme’s (MSD;...
Sino Biopharmaceutical Gains CDE Approval for TQC3721 COPD Trial
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced that it has received approval from the Center...
Huadong Medicine’s HDM1010 Gets FDA Nod for Phase I Trial in T2D
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that it has received approval from the...
Sanyou Biopharma Partners with Medicovestor to Advance Next-Gen ADCs
China-based Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. announced a strategic partnership with US-headquartered Medicovestor, Inc. to...
Huahai Pharma Receives FDA Warning Letter After Inspection
China-based Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) announced that it has received a warning...
Burning Rock Reports Q1 2025 Revenue Growth and R&D Progress
China-based medtech firm Burning Rock Ltd (NASDAQ: BNR) released its Q1 2025 financial report, showing a...
Sinopep Allsino Partners with Vazyme to Advance Synthetic Biology
China-based Jiangsu Sinopep Allsino Biopharmaceutical Co., Ltd. (SHA: 688076) announced a strategic partnership with compatriot...
CIRC and Qianlong International Collaborate to Advance BNCT and Nuclear Medicine
China Isotope & Radiation Corporation (CIRC; HKG: 1763) and Hong Kong-based Qianlong International Holdings Ltd....